(Q50863981)

24 March 2018

title

Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning. (English)

1 reference

24 March 2018

right ventricular hypertrophy

main subject

1 reference

3

1 reference

24 March 2018

Asger Andersen

object named as

Asger Andersen

series ordinal

1

0 references

author name string

Jonas Agerlund Povlsen

series ordinal

2

1 reference

24 March 2018

Jens Erik Nielsen-Kudsk

series ordinal

4

1 reference

24 March 2018

publication date

30 June 2013

1 reference

24 March 2018

European Journal of Heart Failure

published in

1 reference

24 March 2018

volume

15

1 reference

24 March 2018

issue

11

1 reference

24 March 2018

page(s)

1208-1214

1 reference

24 March 2018

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Effect of remote ischaemic preconditioning on ischaemic-reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

A decade of discoveries in cardiac biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Ischemic preconditioning reduces right ventricular infarct size through opening of mitochondrial potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

The effects of cyclic guanylate cyclase stimulation on right ventricular hypertrophy and failure alone and in combination with phosphodiesterase-5 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Animal models of heart failure: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

The impairment of preconditioning-mediated cardioprotection in pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT105

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFT105

1 reference

24 March 2018

1 reference

24 March 2018